Acceptability of a chikungunya vaccine and dengue vaccine among travelers in Martinique (French West Indies), for the travel and for their home territory.

ABSTRACT:

Objectives

The incidence of chikungunya and dengue is increasing worldwide. Vaccines are now available against these two arboviral diseases.

Methods

We evaluated the acceptability of live chikungunya and dengue vaccines (VLA1553 and TAK-003) among users of Martinique's travel clinics from January to April 2025. We asked whether they would want these vaccines for travel to areas with exposure risk and/or for their home territory.

Results

While planning travel, 41% of respondents expressed interest in the chikungunya vaccine, and 55% were interested in the dengue vaccine. For the Martinique territory, 55% were willing to receive the chikungunya vaccine, and 58% were willing to receive the dengue vaccine.

Conclusions

In both contexts (travel and home territory), a

SUBMITTER: Quenard F 

PROVIDER: S-EPMC12664037 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature